(Q45363637)

English

Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India

scientific article published in October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

1 reference

based on heuristic

inferred from title

visceral leishmaniasis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Johan van Griensven

2

object named as

Johan van Griensven

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

author name string

Prabhat K Sinha

1

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Krishna Pandey

3

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Nawin Kumar

4

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Neena Verma

5

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Raman Mahajan

6

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Pankaj Kumar

7

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Ranjeet Kumar

8

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Pradeeb Das

9

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Gaurab Mitra

10

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Laurence Flevaud

11

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Cecilia Ferreyra

12

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Daniel Remartinez

13

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Manuel Pece

14

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Pedro Pablo Palma

15

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

language of work or name

0 references

publication date

1 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

53

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

e91-8

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Liposomal amphotericin B for the treatment of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR521

21 January 2018

Combating tropical infectious diseases: report of the Disease Control Priorities in Developing Countries Project

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR521

21 January 2018

The increase in risk factors for leishmaniasis worldwide

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR521

21 January 2018

The relationship between leishmaniasis and AIDS: the second 10 years

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR521

21 January 2018

Treatment of antimony-unresponsive Indian visceral leishmaniasis with ultra-short courses of amphotericin-B-lipid complex.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR521

21 January 2018

Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR521

21 January 2018

Randomised controlled trial exists of levonorgestrel intrauterine system for menorrhagia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR521

21 January 2018

Visceral leishmaniasis/human immunodeficiency virus co-infection in India: the focus of two epidemics.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR521

21 January 2018

Treatment of leishmaniasis in HIV-positive patients

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR521

21 January 2018

A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR521

21 January 2018

Visceral leishmaniasis and HIV in Tigray, Ethiopia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR521

21 January 2018

Clinical characteristics and treatment outcome of patients with visceral leishmaniasis and HIV co-infection in northwest Ethiopia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR521

21 January 2018

Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR521

21 January 2018

The impact of highly active antiretroviral therapy (HAART) on visceral leishmaniasis in Spanish patients who are co-infected with HIV.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR521

21 January 2018

Effectiveness and Safety of Liposomal Amphotericin B for Visceral Leishmaniasis under Routine Program Conditions in Bihar, India

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR521

21 January 2018

Non-parametric inference for cumulative incidence functions in competing risks studies.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR521

21 January 2018

Competing risk regression models for epidemiologic data

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR521

21 January 2018

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR521

21 January 2018

Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR521

21 January 2018

Single-dose liposomal amphotericin B for visceral leishmaniasis in India

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR521

21 January 2018

A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR521

21 January 2018

Combination therapy for visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR521

21 January 2018

Leishmania–HIV co-infection: An emerging problem in India

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR521

21 January 2018

Identifiers

10.1093/CID/CIR521

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45363637&oldid=2075864580"